Agency Forms Undergoing Paperwork Reduction Act Review, 70831-70832 [2022-25242]
Download as PDF
<![CDATA[
70831
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Mothers (Consent) .................
Linkage to Reportable Infectious Disease Consent.
Residual Newborn Bloodspot
Consent.
2,590 ......................................
1
15/60
1,850 ......................................
1
15/60
Online Occupational Questionnaire.
Supplemental Computer Assisted Telephone Interview.
Authorization Form for Stillbirth COVID–19 Sub-Study.
830 .........................................
1
20/60
640 .........................................
1
25/60
157 .........................................
1
15/60
Mothers (Consent for Residual Newborn Bloodspot Retrieval).
Mothers (Online Questionnaire).
Mothers of AR/MA Stillbirths
and Controls (Interview).
Mothers of AR/MA Stillbirths
with Specimens available
for Testing.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–25243 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–22FT]
Agency Forms Undergoing Paperwork
Reduction Act Review
lotter on DSK11XQN23PROD with NOTICES1
Average
burden per
response
(in hours)
Number of
responses per
respondent
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Enhanced
Surveillance of Respiratory Illness
Among People Experiencing
Homelessness in Anchorage, Alaska’’ to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on June 2, 2022 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
Proposed Project
Enhanced Surveillance of Respiratory
Illness Among People Experiencing
Homelessness in Anchorage, Alaska—
New—National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
People experiencing homelessness are
at higher risk for respiratory infectious
diseases. However, the causes of these
infections are not well understood. This
project involves enhanced surveillance
for organisms that cause respiratory
illness in congregate and non-congregate
homeless shelters to provide evidence to
improve public health for people who
are experiencing homelessness in
Anchorage, Alaska.
The project team will collect an upper
respiratory specimen (e.g.,
nasopharyngeal swab) from people
experiencing respiratory symptoms who
are accessing shelters. A member from
the project team will complete
demographic questions and a short
symptom questionnaire with the
participant. Swabs obtained from study
participants will be tested for multiple
respiratory pathogens to: (1) estimate
the burden of pathogen-specific
respiratory infections among people
experiencing homelessness; (2) inform
infection control; and (3) determine the
vaccination status of people in this
population.
CDC requests OMB approval for an
estimated 500 annual burden hours for
this collection. There is no cost to
respondents other than their time to
participate.
E:\FR\FM\21NON1.SGM
21NON1
70832
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Persons with Respiratory Symptoms Experiencing
Homelessness.
Enrollment in Symptom Screening ..
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–25242 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Deputy
Director for Infectious Diseases (BSC,
DDID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Board of
Scientific Counselors, Deputy Director
for Infectious Diseases (BSC, DDID).
This virtual meeting is open to the
public via Zoom, limited only by the
number of web conference lines
available (500 lines). Pre-registration is
required by accessing the link below in
the addresses section.
DATES: The meeting will be held on
December 7, 2022, from 9:00 a.m. to
5:15 p.m., EST, and December 8, 2022,
from 8:30 a.m. to 1:00 p.m., EST.
ADDRESSES: Zoom virtual meeting. Preregistration is required by accessing the
link at https://cdc.zoomgov.com/
webinar/register/WN_
PbAc34lET9uD2RN8lopzig. Instructions
to access the meeting will be provided
following registration.
FOR FURTHER INFORMATION CONTACT:
Laura Hughes-Baker, Ph.D., Designated
Federal Officer, CDC, 1600 Clifton Road
NE, Mailstop H24–12, Atlanta, Georgia
30329–4027; Telephone: (404) 639–
1402; Email: LHughesBaker@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, DDID provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the CDC
Deputy Director for Infectious Diseases;
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
and the Directors of the National Center
for Emerging and Zoonotic Infectious
Diseases, the National Center for HIV,
Viral Hepatitis, STD, and TB
Prevention, and the National Center for
Immunization and Respiratory Diseases,
CDC, concerning strategies, goals, and
priorities for the programs and research
within the national centers and
monitors the overall strategic direction
and focus of DDID and the national
centers.
Matters to be Considered: The agenda
will include updates and discussions on
recent outbreaks and affected
populations, as well as brief reports
from two of the Board’s workgroups: the
Food Safety Modernization Act
Surveillance Working Group and the
Acute Flaccid Myelitis Task Force.
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–25276 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity: Administration for Children
and Families Program Instruction—
Children’s Justice Act (OMB #0970–
0425)
Children’s Bureau,
Administration for Children and
Families, U.S. Department of Health and
Human Services.
ACTION: Request for Public Comments.
AGENCY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
1,000
Number of
responses
per
respondent
Average
burden per
respons
(in hours)
1
30/60
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the ACF
Program Instruction—Children’s Justice
Act (Office of Management and Budget
(OMB) #0970–0425, expiration 6/30/
2023). There are no changes proposed to
the Program Instruction.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: The Program Instruction,
prepared in response to the enactment
of the Children’s Justice Act, Title II of
Public Law 111–320, Child Abuse
Prevention and Treatment Act
Reauthorization of 2010, provides
direction to the states and territories to
accomplish the purposes of assisting
states in developing, establishing, and
operating programs designed to
improve: (1) the assessment and
investigation of suspected child abuse
and neglect cases, including cases of
suspected child sexual abuse and
exploitation, in a manner that limits
additional trauma to the child and the
child’s family; (2) the assessment and
investigation of cases of suspected child
abuse-related fatalities and suspected
child neglect-related fatalities; (3) the
investigation and prosecution of cases of
child abuse and neglect, including child
sexual abuse and exploitation; and (4)
the assessment and investigation of
cases involving children with
disabilities or serious health-related
problems who are suspected victims of
child abuse or neglect. This Program
Instruction contains information
collection requirements that are found
in Public Law 111–320 at sections
107(b) and 107(d), and pursuant to
receiving a grant award. The
information being collected is required
by statute to be submitted pursuant to
receiving a grant award. The
SUMMARY:
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Pages 70831-70832]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25242]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-22FT]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Enhanced Surveillance of Respiratory
Illness Among People Experiencing Homelessness in Anchorage, Alaska''
to the Office of Management and Budget (OMB) for review and approval.
CDC previously published a ``Proposed Data Collection Submitted for
Public Comment and Recommendations'' notice on June 2, 2022 to obtain
comments from the public and affected agencies. CDC did not receive
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Enhanced Surveillance of Respiratory Illness Among People
Experiencing Homelessness in Anchorage, Alaska--New--National Center
for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
People experiencing homelessness are at higher risk for respiratory
infectious diseases. However, the causes of these infections are not
well understood. This project involves enhanced surveillance for
organisms that cause respiratory illness in congregate and non-
congregate homeless shelters to provide evidence to improve public
health for people who are experiencing homelessness in Anchorage,
Alaska.
The project team will collect an upper respiratory specimen (e.g.,
nasopharyngeal swab) from people experiencing respiratory symptoms who
are accessing shelters. A member from the project team will complete
demographic questions and a short symptom questionnaire with the
participant. Swabs obtained from study participants will be tested for
multiple respiratory pathogens to: (1) estimate the burden of pathogen-
specific respiratory infections among people experiencing homelessness;
(2) inform infection control; and (3) determine the vaccination status
of people in this population.
CDC requests OMB approval for an estimated 500 annual burden hours
for this collection. There is no cost to respondents other than their
time to participate.
[[Page 70832]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per respons
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Persons with Respiratory Symptoms Enrollment in Symptom 1,000 1 30/60
Experiencing Homelessness. Screening.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-25242 Filed 11-18-22; 8:45 am]
BILLING CODE 4163-18-P
